دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Renal impairment and mortality in patients with STEMI and cardiogenic shock/cardiac arrest
Gautam R. Shroff MBBS, Santiago Garcia MD, Christian Schmidt MS, Brynn Okeson MS, Edward Tannenbaum BA, Roberto Pacheco MD, Timothy D. Smith MD, Ross Garberich MS, MBA, Scott Sharkey MD, Frank Aguirre MD, Mark Tannenbaum MD, Daniel Shivapour MD, Teresa Coulson RN, Timothy D. Henry MD
doi : 10.1002/ccd.30753
We sought to study the association of renal impairment (RI) with mortality in ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock and/or cardiac arrest (CS/CA).
Culprit lesion plaque characterization and thrombus grading by high-definition intravascular ultrasound in patients with ST-segment elevation myocardial infarction
Frederik T. W. Groenland MD, Annemieke C. Ziedses des Plantes BSc, Tara Neleman BSc, Alessandra Scoccia MD, Jurgen M. R. Ligthart RT, Karen T. Witberg RN, Karim D. Mahmoud MD, PhD, Rutger-Jan Nuis MD, PhD, Wijnand K. den Dekker MD, PhD, Jeroen M. Wilschut MD, Roberto Diletti MD, PhD, Felix Zijlstra MD, PhD, Nicolas M. Van Mieghem MD, PhD, Joost Daemen MD, PhD
doi : 10.1002/ccd.30699
Dedicated prospective studies investigating high-definition intravascular ultrasound (HD-IVUS)-guided primary percutaneous coronary intervention (PCI) are lacking. The aim of this study was to qualify and quantify culprit lesion plaque characteristics and thrombus using HD-IVUS in patients presenting with ST-segment elevation myocardial infarction (STEMI).
Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: A systematic review and meta-analysis
Douglas Mesadri Gewehr MD, Pedro Emanuel de Paula Carvalho, Caroline Serafim Dagostin MSc, Rhanderson Cardoso MHS, Taiane Belinati Loureiro Kubrusly MD, Fernando Bermudez Kubrusly MD, Luiz Fernando Kubrusly PhD
doi : 10.1002/ccd.30750
Pretreatment with oral P2Y12 inhibitors is a standard practice for ST-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). However, the efficacy and safety of P2Y12 inhibitors pretreatment remain unclear.
Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention
Raffaele Piccolo MD, PhD, Attilio Leone MD, Fiorenzo Simonetti MD, Marisa Avvedimento MD, Domenico Angellotti MD, Lina Manzi MD, Nicola Verde MD, Carmen Anna Maria Spaccarotella MD, Luigi Di Serafino MD, PhD, Plinio Cirillo MD, PhD, Giuseppe Gargiulo MD, PhD, Giuliana Fortunato MD, PhD, Anna Franzone MD, PhD, Giovanni Esposito MD, PhD
doi : 10.1002/ccd.30749
Limited data are available on the risk of periprocedural myocardial infarction (MI) in patients undergoing complex versus noncomplex percutaneous coronary intervention (PCI).
Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry
Ovidio de Filippo MD, Francesco Bruno MD, Tineke H. Pinxterhuis MD, Mariusz GÄ…sior MD, Leor Perl MD, Luca Gaido MD, Domenico Tuttolomondo MD, Antonio Greco MD, Roberto Verardi MD, Gianluca Lo Martire MD, Mario Iannaccone MD, Attilio Leone MD, Gaetano Liccardo MD, Serena Caglioni MD, Rocio González Ferreiro MD, Giulio Rodinò MD, Giuseppe Musumeci MD, Giuseppe Patti MD, Irene Borzillo MD, Giuseppe Tarantini MD, PhD, Wojciech WaÅ„ha MD, Bruno Casella PhD, Eline H. Ploumen MD, PhD, Å�ukasz Pyka PhD, Ran Kornowski MD, Andrea Gagnor MD, Raffaele Piccolo MD, PhD, Sergio Raposeiras Roubin MD, PhD, Davide Capodanno MD, PhD, Paolo Zocca MD, PhD, Federico Conrotto MD, Gaetano M. De Ferrari MD, Clemens von Birgelen MD, PhD, Fabrizio D'Ascenzo MD, PhD, ULTRA Collaborators
doi : 10.1002/ccd.30696
Data about the long-term performance of new-generation ultrathin-strut drug-eluting stents (DES) in challenging coronary lesions, such as left main (LM), bifurcation, and chronic total occlusion (CTO) lesions are scant.
Cost-effectiveness analysis of dyevertâ„¢ Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain
Jose R. López-MÃÂnguez, A. L. MartÃÂn de Francisco, M. J. Soler, Felipe Hernández, Raul Moreno, Eduardo Pinar, A. Sampedro, M. Mareque, I. Oyagüez
doi : 10.1002/ccd.30744
To assess the efficiency of Dyevertâ„¢ Power XT compared to the standard clinical practice when used for percutaneous coronary interventions (PCI).
Balloon assisted hematoma fenestration in spontaneous coronary artery dissection. Case presentation and literature review
George Besis MD, Chiara De Biase MD, PhD, Eduardas Subkovas MD, Roby Rakhit MD
doi : 10.1002/ccd.30683
The management of spontaneous coronary artery dissection (SCAD) is lacking randomized data. This also holds for SCAD with ST-segment elevation myocardial infarction where stenting has been used to restore coronary flow. This approach can be associated with many drawbacks. Therefore, we present an alternative approach to stenting when coronary flow cannot be restored using cutting balloons alone.
Fix and pull technique for retrieval of intracoronary unexpanded-stent entrapment
Ibrahim Yassin MD, Mohamed A. Mosaad MD, Ahmed M. Hassan MD, Mohammad Abdelghani MD, PhD
doi : 10.1002/ccd.30756
During left main (LM) bifurcation PCI using T and small protrusion (TAP) technique, after deployment of LM-left anterior descending (LAD) stent, left circumflex (LCx) stent was entangled at LM ostium with balloon and wire slippage. Ping-pong (dual) guide catheters were used to simultaneously fix the LM-LAD stent and snare the trapped stent. This technique proved effective in retrieving the lost stent and minimizing LM stent deformation.
Comparison of interventions for intermediate to high-risk pulmonary embolism: A network meta-analysis
Yoshiko Ishisaka MD, Atsuyuki Watanabe MD, Tomohiro Fujisaki MD, Masao Iwagami MD, PhD, Matsuo So MD, David Steiger MD, Shunsuke Aoi MD, Eric A. Secemsky MD, MSc, Jose Wiley MD, MPH, Toshiki Kuno MD, PhD, FESC, FSCAI
doi : 10.1002/ccd.30745
Multiple interventions, including catheter-directed therapy (CDT), systemic thrombolysis (ST), surgical embolectomy (SE), and therapeutic anticoagulation (AC) have been used to treat intermediate to high-risk pulmonary embolism (PE), but the most effective and safest treatment remains unclear. Our study aimed to investigate the efficacy and safety outcomes of each intervention.
Novel transcatheter intervention for iatrogenic cyanosis due to surgical rerouting of inferior vena cava to the left atrium
Pramod Sagar MD, DM, Sreeja Pavithran MD, FNB, Kothandam Sivakumar MD, DM
doi : 10.1002/ccd.30757
Improper identification of the atrial septal defect margins during surgery and inadvertent suturing of the surgical patch to the Eustachian valve of the inferior vena cava (IVC) results in the diversion of inferior venacaval blood to the left atrium causing cyanosis. This complication has been dealt so far with surgery. We report the planning and implementation of a novel transcatheter rediversion of the IVC to the right atrium using a covered stent.
Anatomical predictors for suture-based closure of the patent foramen ovale: A multicenter experience
Lars S. Witte MD, Mick P. L. Renkens MD, Aleksandra GÄ…secka MD, PhD, Abdelhak el Bouziani MD, Robbert J. de Winter MD, PhD, Jan G. P. Tijssen PhD, Pieter R. Stella MD, PhD, Gregor Leibundgut MD, Michiel Voskuil MD, PhD
doi : 10.1002/ccd.30691
NobleStitch EL is a novel suture-based technique used for patent foramen ovale (PFO) closure and an alternative to traditional double-disc devices without the need for antithrombotic therapy. However, successful closure rates are still unknown, and certain anatomies may be unfavorable for successful closure.
Achieving PFO closure with the NobleStitch Technique
Bryan Kluck DO, Dzanan Ramic MD, Rahul Gupta MD
doi : 10.1002/ccd.30748
Sex-related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry
Christina Paitazoglou MD, Ingo Eitel MD, Thomas Stiermaier MD, Hueseyin Ince MD, Stephan Kische MD, Evgeny Pokushalov MD, PhD, Thomas Schmitz MD, Boris Schmidt MD, Tommaso Gori MD, Felix Meincke MD, Elisa Vireca, Peter Wohlmuth, Boersma Lucas MD, Martin W. Bergmann MD, PhD, EWOLUTION Investigators
doi : 10.1002/ccd.30759
Women with atrial fibrillation (AF) generally experience worse symptoms, poorer quality of life, and have a higher risk of stroke and death. There is limited availability of sex-related differences regarding left atrial appendage occlusion (LAAO).
Utilization and outcomes of protamine after percutaneous left atrial appendage occlusion
Alejandra Chavez-Ponce MD, Ahmed El Shaer MBBS, Sahar Samimi MD, Samian Sulaiman MD, Alyssa Harris MPH, Mohamad Alkhouli MD
doi : 10.1002/ccd.30743
Novel arm-width-expandable transcatheter edge-to-edge repair system: Preclinical experiment and first-in-human study
The ValveClasp system is a novel transcatheter edge-to-edge repair (TEER) device with an arm-width-expandable clip that allows treatment of patients with only one clip more frequently.
doi : 10.1002/ccd.30758
Postprocedural trans-mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair
Francesco De Felice MD, Luca Paolucci MD, Carmine Musto MD, PhD, Alberta Cifarelli MD, Silvio Coletta MD, Mauro Pennacchi MD, PhD, Rocco Stio MD, PhD, Domenico Gabrielli MD, Carmelo Grasso MD, Corrado Tamburino MD, PhD, Marianna Adamo MD, PhD, Paolo Denti MD, Arturo Giordano MD, PhD, Federico De Marco MD, PhD, Matteo Montorfano MD, Cesare Baldi MD, Annalisa Mongiardo MD, Ida Monteforte MD, Diego Maffeo MD, Cristina Giannini MD, PhD, Gabriele Crimi MD, Giuseppe Tarantini MD, PhD, Antonio Popolo Rubbio MD, Francesco Bedogni MD
doi : 10.1002/ccd.30698
The relationship between high postprocedural mean gradient (ppMG) and clinical events following mitral valve transcatheter edge-to-edge repair (MV-TEER) in patients with degenerative mitral regurgitation (DMR) is still debated.
Anatomic suitability for transapical transcatheter mitral valve implantation using a tether-based device
Philipp Blanke MD, Thomas Modine MD, Alison Duncan MD, Maurizio Taramasso MD, Nicolas Dumonteil MD, Michael L. Chuang MD, Lenard Conradi MD
doi : 10.1002/ccd.30752
Transcatheter mitral valve implantation (TMVI) is a novel therapeutic option for treating symptomatic mitral valve disease. Evaluating patient anatomical suitability is a critical step in the TMVI screening process, but currently requires specialized software and computerized device models.
Transcatheter aortic valve-in-valve implantation within stentless landing zones: Procedural insights from a single-center experience
Frederick M. Lang BS, Nino Mihatov MD, Jacob Kriegel MD, Tamim M. Nazif MD, Torsten P. Vahl MD, Vivian G. Ng MD, Mark Lebehn MD, David Blusztein MD, Thomas J. Cahill MBBS, DPhil, Kyle R. Lehenbauer MD, Rebecca T. Hahn MD, Martin Leon MD, Susheel K. Kodali MD, Isaac George MD
doi : 10.1002/ccd.30755
Valve-in-valve (VIV) transcatheter aortic valve implantation (TAVI) is a less invasive therapeutic option compared with redo surgical valve replacement for high-risk patients. Relative to procedures within stented surgical valves, VIV-TAVI within stentless valves is associated with a higher complication rate due to challenging underlying anatomy and absence of fluoroscopic landmarks.
Cerebral embolic protection during transcatheter aortic valve replacement: Insights from a consecutive series with the Sentinel cerebral protection device
Mathias Wolfrum MD, Federico Moccetti MD, Lucca Loretz MD, Matthias Bossard MD, Adrian Attiger MD, Florim Cuculi MD, Stefan Toggweiler MD
doi : 10.1002/ccd.30697
Growing interest in neuroprotection in transcatheter aortic valve replacement (TAVR) has catalyzed the development of cerebral protection systems (CPS).
Right heart catheterization predictors of symptomatic improvement in patients undergoing transcatheter tricuspid valve edge-to-edge repair
Joshua Rezkalla MD, Yogesh Reddy MBBS, Rick A. Nishimura MD, Ratnasari Padang MBBS, PhD, Sorin V. Pislaru MD, PhD, Charanjit S. Rihal MD, MBA, Mackram F. Eleid MD
doi : 10.1002/ccd.30754
Transcatheter tricuspid valve edge-to-edge repair (TTEER) is associated with improvement in outcomes for symptomatic patients with severe tricuspid regurgitation (TR). However, reliable predictors for clinical success are not yet fully defined.
Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series
Peter Kramer MD, Bernd Opgen-Rhein MD, Felix Berger MD, Johannes Nordmeyer PhD
doi : 10.1002/ccd.30747
Device thromboses after patent foramen ovale (PFO) and atrial septal defect (ASD) closure are rare but serious complications. They have been reported in different devices of virtually all manufacturers.
Resolution of aortic regurgitation due to Venturi effect after device closure of ruptured sinus of Valsalva aneurysm
Dhiraj Kumar MD, DM, DNB, Vishnu Kesavan MD, DM, DrNB, Charan P. Lanjewar MD, DM, FESC, Girish Sabnis MD, DM
doi : 10.1002/ccd.30746
Infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review
Hiroaki Yokoyama MD, Tomoki Ochiai MD, Shigeru Saito MD
doi : 10.1002/ccd.30751
Transcatheter edge-to-edge repair (TEER) is used extensively in patients with symptomatic severe mitral regurgitation and high surgical risk. While prosthetic valve endocarditis is well documented, infective endocarditis (IE) after TEER is a rare occurrence. To date, no study has been conducted on this complication.
The interplay of cardiac hemodynamics in rheumatic triple valve stenosis
Ramanathan Velayutham MD, A Shaheer Ahmed MD, DM
doi : 10.1002/ccd.30742
Rheumatic heart disease is among the common causes of cardiovascular morbidity in developing countries. Here we present the hemodynamic interplay of stenotic rhematic involvement of aortic, mitral, and tricuspid valves in a 35-year-old female. Though noninvasive imaging by echocardiography and doppler has taken the upper hand today, this case illustrates the crucial role of cardiac catheterization in understanding the hemodynamics and patient management of rheumatic multivalvular heart disease.
Impact of vascular complications after transcatheter aortic valve implantation. VASC-OBSERVANT II sub-study
Cristina Aurigemma MD, PhD, Carlo Trani MD, Paola D'Errigo MSc, Marco Barbanti MD, PhD, Fausto Biancari MD, Giuseppe Tarantini MD, PhD, Gennaro Santoro MD, Massimo Baiocchi MD, Giovanni Baglio, Fulvia Seccareccia MSc, Stefano Rosato MSc, the OBSERVANT II Research Group
doi : 10.1002/ccd.30695
Trans-femoral (TF) access is the commonest approach for transcatheter aortic valve implantation (TAVI). However this vascular approach is associated with vascular complications (VC) which in turn have prognostic implications. The aim of this study is to evaluate the clinical impact of access site VC in patients undergoing TAVI with newer generation transcatheter prostheses enrolled in the national observational prospective multicenter study OBSERVANT II.
Prediction of residual ischemia after coronary stenting by quantitative flow ratio modulated by optical coherence tomography: Where we are now and our future perspectives
Nobuaki Suzuki MD, PhD
doi : 10.1002/ccd.30765
Fighting calcification with optical coherence tomography-guided percutaneous coronary intervention. Commentary on the optical coherence tomography-derived predictors of stent expansion in calcified lesions
Shinjo Sonoda MD, PhD, Koichi Node MD, PhD
doi : 10.1002/ccd.30776
“CHIP-ping� away at the definition of PCI “complexity� and “risk�
Adib Chaus MD, Barry F. Uretsky MD
doi : 10.1002/ccd.30779
Moderate aortic stenosis in patients with myocardial infarction: A guilty bystander?
Giorgio Caretta MD, Alberto Menozzi MD, PhD
doi : 10.1002/ccd.30766
Long-term results of M-TEER: A mountain of data with gaps to cross
Firas Zahr MD, Scott Chadderdon MD
doi : 10.1002/ccd.30775
